Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease

Journal of Neural Transmission

Volumn 117, Issue 2, 2010, Pages 197-205

  Skodda, Sabine ^a   Visser, Wenke ^a   Schlegel, Uwe ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Dysarthria; Levodopa effects on speech; Parkinson's disease; Speech disorders

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; LISURIDE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DYSARTHRIA; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; PARKINSON DISEASE; PHONATION; PRIORITY JOURNAL; READING; SHORT COURSE THERAPY; SPEECH ANALYSIS; SPEECH ARTICULATION; SPEECH RATE; TASK PERFORMANCE; VOWEL;

ADULT; AGED; DOPAMINE AGENTS; DYSARTHRIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LANGUAGE TESTS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PHONETICS; READING; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SPEECH; SPEECH PRODUCTION MEASUREMENT; TIME FACTORS;

EID: 77249157706     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0351-5     Document Type: Article

References (58)

1. H Ackermann J Konczak I Hertrich 1997 The temporal control of repetitive articulatory movements in Parkinson's disease Brain Lang 57 312 319 10.1006/brln.1997.1851 (Pubitemid 27184985)
2. LL Azevedo F Cardoso C Reis 2003 Acoustic analysis of prosody in females with Parkinson's disease: effect of l-dopa Arq Neuropsiquiatr 61 995 998 14762605 (Pubitemid 38009310)
3. KK Baker LO Ramig AB Johnson CR Freed 1997 Preliminary voice and speech analysis following fetal dopamine transplants in 5 individuals with Parkinson disease J Speech Lang Hear Res 40 615 626 9210118 1:STN:280:DyaK2szltlyktQ%3D%3D
4. KK Baker LO Ramig ES Luschei ME Smith 1998 Thyroarytenoid muscle activity associated with hypophonia in Parkinson's disease and aging Neurology 51 1592 1598 9855507 1:STN:280:DyaK1M%2FntFWnuw%3D%3D
5. T Benke C Hohenstein W Poewe B Butterworth 2000 Repetitive speech phenomena in Parkinson's disease J Neurol Neurosurg Psychiatry 69 319 324 10.1136/jnnp.69.3.319 10945806 1:STN:280:DC%2BD3cvivFChtQ%3D%3D (Pubitemid 30636235)
6. Boersma P, Weenik D (1996) PRAAT: a system for doing phonetics by computer. Report of the Institute of Phonetic Sciences of the University of Amsterdam. http://www.fon.humuva.nl/praat
7. H Braak K Del Tredici U Rüb RA de Vos EN Jansen Steur E Braak 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211 10.1016/S0197-4580(02)00065-9 12498954 (Pubitemid 36007810)
8. A Bradlow G Torretta D Pisoni 1996 Intelligibility of normal speech I: global and fine-grained acoustic phonetic talker characteristics Speech Commun 20 255 272 10.1016/S0167-6393(96)00063-5
9. J Caekebeke A Jennekens-Schinkel A van der Linden I Buruma R Roos 1991 The interpretation of dysprosody in patients with Parkinson's disease J Neurol Neurosurg Psychiatry 54 145 148 10.1136/jnnp.54.2.145 2019840 1:STN:280:DyaK3M3htVyjtQ%3D%3D
10. MP Caligiuri 1989 The influence of speaking rate on articulatory hypokinesia in parkinsonian dysarthria Brain Lang 36 493 502 10.1016/0093-934X(89)90080-1 2706450 1:STN:280:DyaL1M3gvVWitA%3D%3D (Pubitemid 19105260)
11. N Daniels J Oates DJ Phyland A Feiglin A Hughes 1996 Vocal characteristics and response to levodopa in Parkinson's disease Mov Disord 11 suppl 1 117
12. FL Darley AE Aronson JR Brown 1969 Clusters of deviant speech dimensions in the dysarthrias J Speech Hear Res 12 462 496 5811846 1:STN:280: DyaF1M3ptFGntA%3D%3D
13. FL Darley AE Aronson JR Brown 1969 Differential diagnostic patterns of dysarthria J Speech Hear Res 12 246 269 5808852 1:STN:280:DyaF1M3osVKqsQ%3D%3D
14. M De Letter P Santens J Van Borsel 2003 The effect of levodopa tongue strength and endurance in patients with Parkinson's disease Acta Neurol Belg 103 35 38 12704981
15. M De Letter P Santens J Van Borsel 2005 The effects of levodopa on word intelligibility in Parkinson's disease J Commun Disord 38 187 196 10.1016/j.jcomdis.2004.09.001 15748723 (Pubitemid 40312802)
16. M De Letter P Santens M De Bodt P Boon J Van Borsel 2006 Levodopa-induced alterations in speech rate in advanced Parkinson's disease Acta Neurol Belg 106 19 22 16776432
17. M De Letter P Santens M De Bodt G Van Maele J Van Borsel P Boon 2007 The effects of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease Clin Neurol Neurosurg 109 495 500 10.1016/j.clineuro.2007.04.003 17509751 (Pubitemid 46783198)
18. M De Letter P Santens I Estercam G Van Maele M De Bodt P Boon J Van Borsel 2007 Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners Clin Linguist Phon 21 783 791 10.1080/02699200701538181 17882694 (Pubitemid 47470819)
19. P Doyle A Raade A St Pierre S Desai 1995 Fundamental frequency and acoustic variability associated with production of sustained vowels by speakers with hypokinetic dysarthria J Med Speech Lang Pathol 3 41 50
20. A Flint S Black I Campbell-Taylor G Gailey C Levinton 1992 Acoustic analysis in the differentiation between Parkinson's disease and major depression J Psycholinguist Res 21 383 399 10.1007/BF01067922 1447729 1:STN:280: DyaK3s%2FnvVWqtg%3D%3D
21. K Forrest G Weismer 1995 Dynamic aspects of lower lip movement in parkinsonian and neurologically normal geriatric speakers' production of stress J Speech Hear Res 38 260 272 7596092 1:STN:280:DyaK2MzhvFWhsA%3D%3D
22. J Gamboa FJ Jimenez-Jimenez A Nieto 1997 Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs J Voice 11 314 320 10.1016/S0892-1997(97)80010-0 9297676 1:STN:280:DyaK2svkt1Oisw%3D%3D (Pubitemid 27377220)
23. AM Goberman M Blomgren 2003 Parkinsonian speech disfluencies: effects of l-dopa related fluctuations J Fluency Disord 28 55 70 10.1016/S0094-730X(03) 00005-6 12706913 (Pubitemid 36438619)
24. AM Goberman C Coelho 2002 Acoustic analysis of parkinsonian speech I: speech characteristics and l-dopa therapy NeuroRehabilitation 17 237 246 12237505 (Pubitemid 35025012)
25. AM Goberman C Coelho M Robb 2002 Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states J Commun Disord 35 217 239 10.1016/S0021-9924(01)00072-7 12064785 (Pubitemid 34665409)
26. AK Gobermann 2005 Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson disease Med Sci Monit 11 109 116
27. L Hartelius P Svensson 1994 Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey Folia Phoniatr Logop 46 9 17 10.1159/000266286 8162135 1:STN:280:DyaK2c3hsVKjsw%3D%3D
28. I Hertrich H Ackermann 1995 Gender-specific vocal dysfunction in Parkinson's disease: electroglottographic and acoustical analyses Ann Otol Rhinol Laryngol 104 197 202 7872602 1:STN:280:DyaK2M7nslClsA%3D%3D
29. H Hirose S Kiritani M Sawashima 1982 Velocity of articulatory movements in normal and dysarthric subjects Folia Phoniatr Logop 34 210 215 10.1159/000265651 1:STN:280:DyaL3s%2FotVymsg%3D%3D
30. AK Ho JL Bradshaw R Iansek 2008 For better or worse: the effect of levodopa on speech in Parkinson's disease Mov Disord 23 575 580 10.1002/mds.21899
31. RJ Holmes J Oates D Phyland A Hughes 2000 Voice characteristics in the progression of Parkinson's disease Int J Lang Commun Disord 35 417 418
32. O Hornykiewicz 1998 Biochemical aspects of Parkinson's disease Neurology 51 suppl 2 S2 S9 9711973 1:CAS:528:DyaK1cXlsFeit7Y%3D
33. AJ Hughes SE Daniel L Kilford AJ Lees 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184 10.1136/jnnp.55.3.181 1564476 1:STN:280:DyaK383is1Omsg%3D%3D
34. C Hunker J Abbs S Barlow 1982 The relationship between parkinsonain rigidity and hypokinesia in the orofacial system: a quantitative analysis Neurology 32 749 754 7201112 1:STN:280:DyaL383itVClsA%3D%3D
35. J Jiang E Lin J Wang D Hanson 1999 Glottographic measures before and after levodopa treatment in Parkinson's disease Laryngoscope 109 1287 1294 10.1097/00005537-199908000-00019 10443835 1:STN:280:DyaK1MzntFCgtw%3D%3D (Pubitemid 29379441)
36. F Jimenez-Jimenez J Gamboa A Nieto M Guerrero M Orti-Pareja J Molina E Garcia-Albea I Cobeta 1997 Acoustic voice analysis in untreated patients with Parkinson's disease Park Rel Disord 3 111 116 10.1016/S1353-8020(97)00007-2 1:STN:280:DC%2BD1cvitFyisw%3D%3D (Pubitemid 28090192)
37. RD Kent G Weismer J Kent J Rosenbek 1998 The dysarthrias: speech-voice profiles, related dysfunctions, and neuropathology J Med Speech Lang Pathol 6 165 187
38. K Kompoliti QE Wang CG Goetz S Leurgans R Raman 2000 Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease Neurology 54 458 462 10668714 1:CAS:528:DC%2BD3cXhtV2nsL4%3D
39. K Larson L Ramig R Scherer 1994 Acoustic and glottographic voice analysis during drug-related fluctuations in Parkinson's disease J Med Speech Lang Pathol 2 227 239
40. R Leanderson B Meyerson A Persson 1971 Effect of l-dopa on speech in parkinsonism: an EMG study of labial articulatory function J Neurol Neurosurg Psychiatry 34 679 681 10.1136/jnnp.34.6.679 5158782 1:STN:280: DyaE387htVyjug%3D%3D
41. ES Luschei LO Ramig KL Baker ME Smith 1999 Discharge characteristics of laryngeal single motor units during phonation in young and older adults and in persons with Parkinson's disease Neurophysiol 81 2131 2139 1:STN:280: DyaK1M3lsFKhsg%3D%3D
42. CD Marsden 1994 Parkinson's disease J Neurol Neurosurg Psychiatry 57 672 681 10.1136/jnnp.57.6.672 7755681 1:STN:280:DyaK2c3nsFCltQ%3D%3D
43. J Metter W Hanson 1986 Clinical and acoustical variability in hypokinetic dysarthria J Commun Disord 19 347 366 10.1016/0021-9924(86)90026-2 3490498 1:STN:280:DyaL2s%2FjsVCjsQ%3D%3D
44. J Möbes G Joppich F Stiebritz R Dengler C Schröder 2008 Emotional speech in Parkinson's disease Mov Disord 23 824 829 10.1002/mds.21940 18307245
45. K Nakano H Zubick H Tyler 1973 Speech defects of parkinsonian patients: effects of levodopa therapy on speech intelligibility Neurology 23 865 870 4737081 1:STN:280:DyaE3s3it1Khuw%3D%3D
46. AT Neel 2008 Vowel space characteristics and vowel identification accuracy J Speech Lang Hear Res 51 574 585 10.1044/1092-4388(2008/041) 18506036 (Pubitemid 351962109)
47. R Netsell B Daniel GG Celesia 1975 Acceleration and weakness in parkinsonian dysarthria J Speech Hear Dis 40 170 178 1:STN:280: DyaE2s%2FpvVGmuw%3D%3D
48. KS Perez LO Ramig ME Smith C Dromey 1996 The parkinson larynx: tremor and videoscopic findings J Voice 10 354 361 10.1016/S0892-1997(96)80027-0 8943139 1:STN:280:DyaK2s%2FpvVGquw%3D%3D
49. M Picheny N Durlach L Braida 1986 Speaking clearly for the hard of hearing II: acoustic characteristics of clear and conversional speech J Speech Hear Res 29 434 446 3795886 1:STN:280:DyaL2s%2FovVWmug%3D%3D
50. PC Poluha HL Teulings RH Brookshire 1998 Handwriting and speech changes across the levodopa cycle in Parkinson's disease Acta Psychol (Amst) 35 217 239
51. N Roy SL Nissen C Dromey S Sapir 2009 Articulatory changes in muscle tension dysphonia: evidence for vowel space expansion following manual circumlaryngeal therapy J Commun Disord 42 124 135 10.1016/j.jcomdis.2008.10.001 19054525
52. K Samra M Riklan E Levita 1969 Language and speech correlates of anatomically verified lesions in thalamic surgery for parkinsonism J Speech Hear 12 510 514 1:STN:280:DyaF1M3ptFGnug%3D%3D
53. J Sanabria PG Ruiz R Gutierrez F Marquez P Escobar M Gentil C Cenjor 2001 The effect of levodopa on vocal function in Parkinson's disease Clin Neuropharmacol 24 99 102 10.1097/00002826-200103000-00006 11307045 1:CAS:528:DC%2BD3MXjtlSms78%3D (Pubitemid 32294685)
54. GM Schulz T Peterson CM Sapienza M Greer G Friedmann 1999 Voice and speech characteristics of persons with Parkinson's disease pre- and post-pallidotomy surgery: preliminary findings J Speech Lang Hear Res 42 1176 1194 10515514 1:STN:280:DyaK1MvktlGgtQ%3D%3D
55. S Skodda U Schlegel 2008 Speech rate and rhythm in Parkinson's disease Mov Disord 23 985 992 10.1002/mds.21996 18383114
56. S Skodda A Rinsche U Schlegel 2009 Progression of dysprosody in Parkinson's disease: a longitudinal study Mov Disord 24 716 722 10.1002/mds.22430 19117364
57. P Stevensson C Henningson S Karlsson 1993 Speech motor control in Parkinson's disease: a comparison between a clinical assessment protocol and a quantitative analysis of mandibular movements Folia Phoniatr (Basel) 45 157 164 10.1159/000266243
58. VI Wolfe JS Garvin M Bacon W Waldrop 1975 Speech changes in Parkinson's disease during treatment with l-dopa J Commun Disord 8 271 279 10.1016/0021-9924(75)90019-2 802977 1:STN:280:DyaK3c%2FgvFCntw%3D%3D